Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) With LACTEOL® 340 mg

NCT01358708 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

26

Enrollment

INDUSTRY

Sponsor class

Stopped Administrative reasons

Conditions

Diarrhea-predominant Irritable Bowel Syndrome

Interventions

DRUG: LACTEOL® 340 mg
DRUG: PLACEBO

Sponsor

Forest Laboratories